2A3S6-IMI510Patient Monitor

Rev1/26/2023 InfiniumMedical,Inc FederalCommunicationsCommission AuthorizationandEvaluationDivision 7435OaklandMillsRoad Columbia,MD21046 USA Companyname:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ProductName:PatientMonitor FCCID:2A3S6-IMI510 Model(s):AlphaPM22 Ref:AttestationStatementsPart2.911(d)(5)(ii)Filing We,[InfiniumMedicalInc.](“theapplicant”)certifiesthat,asofthedateofthefilingofthe application,theapplicantisnotidentifiedontheCoveredList(asaspecificallynamedentityor anyofitssubsidiariesoraffiliates)asanentityproducing“covered”equipment. YoursSincerely, Name:NickWilkinsDate:2024.08.02 Title:DirectorofQualityAssuranceandRegulatoryAffairs Signatureofapplicant:

Rev1/26/2023 InfiniumMedical,Inc FederalCommunicationsCommission AuthorizationandEvaluationDivision 7435OaklandMillsRoad Columbia,MD21046 USA Companyname:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ProductName:PatientMonitor FCCID:2A3S6-IMI510 Model(s):AlphaPM22 Ref:AttestationStatementsPart2.911(d)(5)(i)Filing We,[InfiniumMedicalInc.](“theapplicant”)certifiesthattheequipmentforwhich authorizationissoughtisnot“covered”equipmentprohibitedfromreceivinganequipment authorizationpursuanttosection2.903oftheFCCrules. YoursSincerely, Name:NickWilkinsDate:2024.08.02 Title:DirectorofQualityAssuranceandRegulatoryAffairs Signatureofapplicant:

Rev1/26/2023 Infinium Medical Inc, Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia MD 21046, USA Date: 2024 08 026.. Ref: Attestation Statements Part 2.911(d) (7) Filing We, [Infinium Medical,Inc ] (“the applicant”) certifies that, as of the date of the filing of the application, designate our self as U.S. agent for service of process. Designated U.S. Agent Information: Name: Infinium Medical Inc, Address: 12151 62nd St. N. #5 Largo Florida, 33773,United States Contact Person: Nick Wilkins Tel : 1-886-918-8434. Email: [email protected] FRN: 0003766102 FCC ID：2A3S6-IMI510 Sincerely, Applicantsignature: Applicantprintedname:NickWilkins CompanyName:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates Email:[email protected]

InfiniumMedical,Inc OfficeofEngineeringTechnology FederalCommunicationsCommission 7435OaklandMillsRoad Columbia,MD21046 Date:2024.08.26 Subject;RequestforConfidentiality FCCID:2A3S6-IMI510 ToWhomItMayConcern, PursuanttotheprovisionsoftheCommission’srulesTitle47Sections§0.457and§0.459,weare requestingtheCommissiontowithholdthefollowingattachment(s)asconfidentialdocumentsfrom publicdisclosureindefinitely. Thesedocumentscontaindetailedsystemandequipmentdescriptionsandareconsideredasproprietary informationinoperationoftheequipment.Thepublicdisclosureofthesedocumentsmightbeharmfulto ourcompanyandwouldgivecompetitorsanunfairadvantageinthemarket. SchematicDiagram BlockDiagram OperationalDescription Inadditionaltoabovementioneddocuments,inordertocomplywiththemarketingregulationsinTitle 47CFR§2.803andtheimportationrulesinTitle47CFR§2.1204,whileensuringthatbusinesssensitive informationremainsconfidentialuntiltheactualmarketingofnewlyauthorizeddevices,werequestShort TermConfidentialityofthefollowingattachment(s); ExternalPhotos TestSetupPhotos InternalPhotos UserManual For45days,pursuanttoPublicNoticeDA04-1705. OR For180dayspursuanttoKDB726920D01. Itisourunderstandingthatallmeasurementtestreports,FCCIDlabelformatandcorrespondenceduring thecertificationreviewprocesscannotbegrantedasconfidentialdocumentsandthisinformationwillbe availableforpublicreviewoncethegrantofequipmentauthorizationisissued. Sincerely, Signature: Name:NickWilkins

LetterofAuthorization Company:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates ProductName:PatientMonitor ModelNumber:AlphaPM22 FCCID:2A3S6-IMI510 WeauthorizeMiCOMLabsInc,575BoulderCourt,Pleasanton,California94566,USA, toactonourbehalfonallmattersconcerningtheabovenamedequipment. AnyindividualwithinMiCOMLabsisauthorizedtoactonourbehalfandtakeactionon theapplication. WedeclarethatMiCOMLabsInc,575BoulderCourt,Pleasanton,California94566, USA,isallowedtoforwardallinformationrelatedtotheapprovalprojecttotheFederal CommunicationCommissionandtodiscussanyissuesconcerningtheapproval application.AnyandallactscarriedoutbyMiCOMLabsonourbehalfshallhavethe sameeffectasactsofourown. Name:NickWilkinsDate:2024.08.02 Title:DirectorofQualityAssuranceandRegulatoryAffairs Signatureofapplicant:

ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page1of8 RFMPEREPORT ReportNo.:20240517G08542X-W3 ProductName:PatientMonitor ModelNo.:TM1 FCCID:2A3S6–IMI510 Applicant:InfiniumMedical,Inc Address:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates DatesofTesting:07/01/2024-07/12/2024 Issuedby:CCICSouthernTestingCo.,Ltd. LabLocation: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet, NanshanDistrict,Shenzhen,Guangdong,China. Tel：8675526627338E-Mail：[email protected] Thistestreportconsistsof8pagesintotal.Itmaybeduplicatedcompletelyforlegalusewith theapprovaloftheapplicant.Itshouldnotbereproducedexceptinfull,withoutthewritten approvalofourlaboratory.Theclientshouldnotuseittoclaimproductendorsementby CCIC-SET.Thetestresultsinthereportonlyapplytothetestedsample.Thetestreportshall beinvalidwithoutallthesignaturesoftestingengineers,reviewerandapprover.Any objectionsmustberaisedtoCCIC-SETwithin15dayssincethedatewhenthereportis received.Itwillnotbetakenintoconsiderationbeyondthislimit. ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page2of8 TestReport Product......................................:PatientMonitor BrandName ............................. : TradeName............................: Applicant...................................:InfiniumMedical,Inc ApplicantAddress .................. :1215162ndSt.N.#5LargoFlorida,33773,UnitedStates Manufacturer ............................ :InfiniumMedical,Inc ManufacturerAddress...........:1215162ndSt.N.#5LargoFlorida,33773,UnitedStates TestStandards........................:47CFRPart2.1091 TestResult ................................ :Pass Testedby.................................: 2024.07.17 KimLi,TestEngineer Reviewedby.............................: 2024.07.17 SunJiaohui,SeniorEngineer Approvedby............................: [盖章] 2024.07.17 ChrisYou,Manager ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page3of8 TableofContents 1.GENERALINFORMATION....................................................................................................5 1.1.EUTDescription.......................................................................................................................5 1.2.EUTDescription.......................................................................................................................6 1.3.LaboratoryFacilities.................................................................................................................6 1.4.LaboratoryLocation.................................................................................................................6 2.TECHNICALREQUIREMENTSSPECIFICATIONINCFRTITLE47PART2.1091...7 2.1.ExposureLimits........................................................................................................................7 2.2.PredicationofMPElimitatagivendistance...........................................................................7 2.3.EvaluationResults....................................................................................................................8 2.4.Conclusion................................................................................................................................8 ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page4of8 ChangeHistory IssueDateReasonforchange 1.02024.07.17Firstedition ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page5of8 1.GENERALINFORMATION 1.1.EUTDescription ProductNamePatientMonitor EUTsupportsRadiosapplication2.4GWIFI FrequencyRange(Tx) 2.4GWIFI:2.412GHz~2.462GHz Bandwidth 802.11b/g/n-HT20:20MHz 802.11n-HT40:40MHz ModulationType2.4GWIFI:DSSS(802.11b),OFDM(802.11g/n) Antennagain2.4GWIFI:1.99dBi AntennaTypeInternalAntenna Note1:Theinformationofantennagainandcablelossisprovidedbythemanufacturerandourlabis notresponsiblefortheaccuracyoftheantennagainandcablelossinformation. ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page6of8 1.2.EUTDescription EUThasbeentestedaccordingtothefollowingstandards. No.IdentityDocumentTitle 147CFRPart1PracticeandProcedure 247CFRPart2 FrequencyAllocationsandRadioTreatyMatters;General RulesandRegulations 3 KDB447498D01General RFExposureGuidancev06 RFExposureProceduresandEquipmentAuthorization PoliciesforMobileandPortableDevices 4 OETBulletin65 Edition97-01 EvaluatingCompliancewithFCCGuidelinesforHuman ExposuretoRadiofrequencyElectromagneticFields 1.3.LaboratoryFacilities FCC-RegistrationNo.:CN1283 CCICSouthernTestingCo.,LtdEMCLaboratoryhasbeenregisteredandfullydescribedinareport filedwiththeFCC(FederalCommunicationsCommission).TheacceptanceletterfromtheFCCis maintainedinourfiles.DesignationNumber:CN1283,validtimeisuntilJun.30th,2025. ISEDRegistration:11185A-1 CCICSouthernTestingCo.,Ltd.EMCLaboratoryhasbeenregisteredbyCertificationand EngineeringBureauofIndustryCanadafortheperformanceofradiatedmeasurementswith RegistrationNo.11185AonAug.04,2016,validtimeisuntilJun.30th,2025. CABnumber:CN0064 A2LACode:5721.01 CCIC-SETisathirdpartytestingorganizationaccreditedbyA2LAaccordingtoISO/IEC17025. Theaccreditationcertificatenumberis5721.01. 1.4.LaboratoryLocation CompanyName:CCICSouthernTestingCo.,Ltd. Address: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet,Nanshan District,Shenzhen,Guangdong,China ReportNo.:20240517G08542X-W3 CCIC-SET/TRF:IRF(2024-04-29) Page7of8 2.TechnicalRequirementsSpecificationinCFRTitle47Part2.1091 2.1.ExposureLimits Thecriterialistedinthefollowingtableshallbeusedtoevaluatetheenvironmentimpactofhuman exposuretoradiofrequency(RF)radiationasspecifiedin1.1307(b). Table1to§1.1310(e)(1)-LimitsforMaximumPermissibleExposure(MPE) FrequencyRange (MHz) ElectricField Strength (V/m) MagneticField Strength (A/m) PowerDensity (mW/cm2) AveragingTime (minutes) (i)LimitsforOccupational/ControlledExposure 0.3-3.06141.63*(100)<6 3.0-301824/f4.89/f*(900/f 2 )<6 30-30061.40.1631.0<6 300-1500//f/300<6 1500-100,000//5<6 (ii)LimitsforGeneralPopulation/UncontrolledExposure 0.3-1.346141.63*(100)<30 1.34-30824/f2.19/f*(180/f 2 )<30 30…

Text truncated - open the document above for the full version.

ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page1of58 RFTESTREPORT ReportNo.:20240517G08542X-W2 ProductName:PatientMonitor ModelNo.:TM1 FCCID:2A3S6–IMI510 Applicant:InfiniumMedical,Inc Address:1215162ndSt.N.5LargoFlorida,33773,UnitedStates DatesofTesting:07/01/2024-07/12/2024 Issuedby:CCICSouthernTestingCo.,Ltd. LabLocation: ElectronicTestingBuilding,No.43,ShaheRoad,XiliStreet, NanshanDistrict,Shenzhen,Guangdong,China. [email protected] Thistestreportconsistsof58pagesintotal.Itmaybeduplicatedcompletelyforlegaluse withtheapprovaloftheapplicant.Itshouldnotbereproducedexceptinfull,withoutthe writtenapprovalofourlaboratory.Theclientshouldnotuseittoclaimproductendorsement byCCIC-SET.Thetestresultsinthereportonlyapplytothetestedsample.Thetestreport shallbeinvalidwithoutallthesignaturesoftestingengineers,reviewerandapprover.Any objectionsmustberaisedtoCCIC-SETwithin15dayssincethedatewhenthereportis received.Itwillnotbetakenintoconsiderationbeyondthislimit. ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page2of58 TestReport Product......................................:PatientMonitor BrandName ............................. : TradeName............................: Applicant...................................:InfiniumMedical,Inc ApplicantAddress .................. :1215162ndSt.N.5LargoFlorida,33773,UnitedStates Manufacturer ............................ :InfiniumMedical,Inc ManufacturerAddress...........:1215162ndSt.N.5LargoFlorida,33773,UnitedStates TestStandards........................: 47CFRPart15SubpartC ANSIC63.10-2020 TestResult ................................ :Pass Testedby.................................: 2024.07.17 KimLi,TestEngineer Reviewedby ............................. : 2024.07.17 SunJiaohui,SeniorEngineer Approvedby............................: [盖章] 2024.07.17 ChrisYou,Manager ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page3of58 TLOONTNTS 1.GENERALINFORMATION....................................................................................................5 1.1.EUTDescription.......................................................................................................................5 1.2.TestStandardsandResults.......................................................................................................6 1.3.ChannelList..............................................................................................................................6 1.4.Testenvironmentandmode......................................................................................................7 1.5.TableforSupportingUnits.......................................................................................................7 1.6.EUTOperationTestSetup........................................................................................................7 1.7.LaboratoryFacilities.................................................................................................................8 2.TESTREQUIREMENTS..........................................................................................................9 2.1.Antennarequirement................................................................................................................9 2.2.MaximumConductedOutputPower......................................................................................10 2.3.6dBand99Bandwidth........................................................................................................12 2.4.Powerspectraldensity(PSD).................................................................................................14 2.5.ConductedBandEdgesandSpuriousEmissions...................................................................16 2.6.RadiatedBandEdgeandSpuriousEmission..........................................................................18 2.7.ACPowerLineConductedEmission.....................................................................................32 3.LISTOFMEASURINGEQUIPMENT.................................................................................36 4.UNCERTAINTYOFEVALUATION.....................................................................................37 APPENDIXA..................................................................................................................................38 ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page4of58 ChangeHistory IssueDateReasonforchange 1.02024.07.17Firstedition ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page5of58 1.GENERALINFORMATION 1.1.EUTDescription ProductNamePatientMonitor EUTsupportsRadios application WLAN2.4GHz802.11b/g/n(HT20/HT40) FrequencyRange 802.11b/g/n-20MHz:2.412GHz~2.462GHz 802.11n-40MHz:2.422GHz-2.452GHz ChannelNumber 802.11b/g/n-20MHz:11 802.11n-40MHz:7 TransferRate 802.11b:11/5.5/2/1Mbps 802.11g:54/48/36/24/18/12/9/6Mbps 802.11n:upto150Mbps ModulationTypeDSSS(802.11b),OFDM(802.11g/n) AntennaTypeInternalAntenna AntennaGain1.99dBi PowersupplyRechargeableLi-ionBatteryDC7.2V/2550mAh Note1:Foramoredetaileddescription,pleaserefertoSpecificationorUser’sManualsuppliedby theapplicantand/ormanufacturer. Note2:TheEUTwasprogrammedtobeincontinuouslytransmittingmodeandthetransmitduty cycleisnotlessthan98. Note3:Theinformationofantennagainandcablelossisprovidedbythemanufacturerandourlabis notresponsiblefortheaccuracyoftheantennagainandcablelossinformation. ReportNo.:20240517G08542X-W2 CCIC-SET/TRF:IRF(2024-04-29) Page6of58 1.2.TestStandardsandResults ThepurposeofthereportistoconducttestingaccordingtothefollowingFCCcertification standards: No.IdentityDocumentTitle 1 47CFRPart15 SubpartC RadioFrequencyDevices 2 KDB558074D01 15.247MeasGuidance v05r02 CuidanceforComplianceMeasurementonDigital TransmissionSystems,FrequencyHoppingSpreadSpectrum Systems,andHybridSystemDevicesOperatingunderSection 15.247oftheFCCRules 4ANSIC63.10-2020 AmericanNationalStandardforTestingUnlicensedWireless Devices Testdetaileditems/sec…

Text truncated - open the document above for the full version.

᢯䇔Җ亩ⴞ㺘 Spec Item NO.ᇩ˄޵Contents˅ 亥ᮠ ˄Number of Page˅ 亥⸱ ˄Page Code˅ 1 ᢯䇔Җሱ䶒˄Spec Cover˅ 1 1 2᢯䇔Җ亩ⴞ㺘˄Spec Item ˅1 2 3ᐕ〻ᡀ૱മ˄Drawing˅1 3 4⭥ᙗ⍻䈅ᣕ੺˄Test Reports ˅1 4 5 S৲ᮠ⍻䈅˄S Parameter˅ 15 6 ⍻䈅䇮༷˄ Test Equipment˅ 16 7 ᯩੁമ(Patten) 17 8 ⍻䈅᭸⦷˄Test Efficiency˅ 18 9 ṧ૱Ự傼䇠ᖅ˄Sample inspection˅ 19 10 ᶀ䍘䇱᰾˄Material Certificate˅ 310~12 ! !     ⭥ᙗ⍻䈅ᣕ੺ Test Reports      ! ! Electrical Properties Frequency2.4~2.5GHz(ᑖᵪ⍻䈅) Impedance50 0hm Nominal V.S.W.Rİ1.92 Return Loss-10 dB Max RadiationOmni-directional Gain (Peak) PolarizationLinear, Vertical Admitted Power2 W Connector ,3(; Physical Properties Antenna Material PCB Cable Type Ï1.13mmGray Operating Temp. -~+ ̊C Storage Temp. -0~+8 ̊C  1.99 dBi ! ! ! ! T⍪㔘㳳孽! 63DUDPHWHU7HVW  $JLOHQW(&1HWZRUN$QDO\]HU  :,),$QWHQQD 12           ! ! ⍻䈅䇮༷ Test Setup NFC-500S 3D Chamber Coordinate System Definition Configuration of 3D Chamber    ! !      ᯩੁമ Patten 1.3 2D Radiation patterns test results (Passive Antenna) XZ Plane YZ Plane 1.5 3D Radiation patterns test results (Passive Antenna) 3D  ! !  ! !    ⍻䈅᭸⦷ 7HVW(IILFHQF\   SFF-50-0.6 (1. 13) ．．．．．．． ， 1 2 3 4 型号Cable Type 结构S衍ucture 1 内导体E 掣肘， eo11dot伽 SFF-50-0.6 (1. 13) 2绝缘体Diel配时C 3纺织层Braideollductor 4 护套Jacket (Gra y ) 电性能参数ElectricalCharacteristics 电容0-pa_ci钮’回(pF/m) 阪抗lmpeda 凰”。b m) 速率Ve loc_ity（当｝ 直流电姐Conductor�届总细nce(O战 m) 检驳电压 Worki吨voltage伍VMS’ 工作温度范围 Operating Temp. （°C｝ 衰减（典型值）Attenua由mσ'ypical)（寿础Im) 频率Frequenc y l GHz 2 GHz 3 GHz 4 GHz 5 GHz 6 G在iz 应用Application 应用于高频传输，特别是发级机、接收器、电脑、无线电设备、视频信号、射频信号传 输．同轴电缆保证各式机城、热力、电子设备中能达到GHz商频层次的应用． α地xialcables are used in high frequency trans相ission,especially for transmiters and receivers.co四puters,radio and TV transmissions. The varied mechanical,thermal创d electronic properties of Coaxial cables mean that they can be used up into the GHz levels, as pes cable type. Cu-silverplated 7×0.创始回eo.2也m FEP <t 0. 68士0.05皿 98 50土2.0 ’S M 唱 团 1 － 车 1.0 105 2.0 2.9 3.7 4. 3 4.8 5.3 ⠽⠽䋼៤ӑ㸼 MA TERIAL COMPOSITION SHEET XTⱘFR-4ѻકЏ㽕⬅ᷥ㛖ǃ䪰ᇈǃ⦏⩗Ꮧ㒘៤ˈ⦄ᇚ䖭ѯᴤ᭭ⱘ៤ӑ߫㸼བϟ Ingredients of FR-4 XT are˖Epoxy ResinǃCopper FoilǃFibcr Glass as listed blow. Џ㽕ᵘ៤ Main Composition NO. ៤ߚৡ鹵 Ingredient s ᠔ऴᵓᴤ ⱒߚ↨˄%˅ ⠽䋼ৡ鹵 Material ⱒߚ↨˄%˅ 1.࣪⦃⇻ᷥ㛖 Epoxy Resin 99.97% 1 ⦃⇻ᷥ㛖 Epoxy Resin 37-40% ∈㾷∃ CI 0.02-0.035% 䪰 Cu 99.9% 䪈 Co 0.028% 䬄 Mn 0.018% 䫀 Cr 0.004% 2 ⬉㾷䪰ᇈ Copper Foil 15-20% 䫠 Zn 0.01% SiO 2 52-56% CaO16-25% Al 2 O 3 12-16% MgO0-5% B 2 O 3 5-10% Na 2 O&K 2 O0-2% Fe 2 O 3 0.05-0.4% Ti O 2 0-0.8% 3 ⬉ᄤ㑻⦏⩗Ꮧ Fibcr Glass 40-45% F 2 0-1.0% ⊼˖1DŽҹϞ៤ӑഛЎ䞡䞣ⱒߚ↨˄Weight Percentage ˅. 2ˊ1.࣪⦃⇻ᷥ㛖Ё1.ⱘ৿䞣ऴ17-21% 东莞市森岭Ც㜭、ᢰ有限公司